ARTICLE | Company News
Immunocore taps MedImmune's Jallal as CEO
January 4, 2019 8:30 PM UTC
TCR company Immunocore Ltd. (Abingdon, U.K.) hired Bahija Jallal as CEO. She was EVP of AstraZeneca plc (LSE:AZN; NYSE:AZN) and president of its MedImmune LLC subsidiary.
Jallal, who joined MedImmune in 2006, oversaw the development of multiple drugs including anti-PD-L1 mAb Imfinzi durvalumab and asthma drug Fasenra benralizumab. She also helped augment the company's pipeline to 130 molecules from 40 across multiple therapeutic areas, including cancer, cardiovascular, autoimmune and infectious diseases. ...